SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.07-3.4%Nov 20 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOEBT1 who wrote (18948)4/12/1998 12:48:00 PM
From: squetch  Read Replies (1) of 32384
 
I found this paper from Wyeth-Ayerst.

TNF-alpha and 9-cis-RA Synergistically Induce ICAM-1 Expression: Evidence for Interaction of Retinoid Receptors w/ NF-kB

>>This study provides the first demonstration fo a synergistic control of ICAM-1 protein expression by TNF-alpha and 9-cis-RA...In summary, this study demonstrates that ICAM-1 is synergistically regulated at the transcriptional level by TNF-a and 9-cis, via the functional interaction of NF-kB p65 homodimers w/ RAR/RXR heterodimers. Since enhanced ICAM-1 expression occurs in a number of diseases and pathological conditions, including atherosclerosis, arthritis, nephritis, and stroke, it is possibe that retinoid receptor/NF-kB(Nuclear factor kappa B) interaction may play a role in the progression of such disaeses.<<

Experimental Cell Research 239, 423-429 Chadwick, Shaw and Winneker
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext